What Biopuremax does

Biopuremax is a privately held Israeli company, headquartered in Herzliya, that designs, supplies, and commissions standardized pharmaceutical water purification systems for the pharmaceutical and biotech industries. The company produces Purified Water (PW) and Water for Injection (WFI) systems using a chemical-free, media-free architecture that the company claims delivers up to 30% feed water savings versus traditional pretreatment. Founded with over 20 years of operating history in biopharmaceutical water systems, Biopuremax serves enterprise customers including Teva, Kamada, Pluristem, Taro Pharmaceutical, Omrix, VBL, TECPAR (Brazil), Theraskin (Brazil), and Accord (UK), with geographic reach spanning Israel, Brazil, Germany, the UK, the Netherlands, Turkey, and Canada.

The company's technical core is four proprietary, trademarked technologies: ESR (Electrolytic Scale Reduction), which precipitates scale-forming ions via a metallic reaction chamber with a central electrode; HOD (Hydro Optical De-Chlorination), a UV-based process that reduces free chlorine and disinfects water; CBR (Continuous Bioburden Reduction), which combines ESR-generated chlorine with HOD UV for ongoing bacterial control; and HWS (Hot Water Sanitization) at 80–90°C. These pretreatment modules feed into RO, CEDI, and Ultra Filtration systems to produce PW and WFI compliant with USP, European Pharmacopeia, and ISO 22519, with the company's ESR and HOD technologies explicitly codified in ISO 22519 (June 2019) and recognized in the ISPE Baseline Good Practice Guide. Capacity range is 0.5 m3/hr to 9.5 m3/hr, and systems are delivered with full Factory Acceptance Testing, SAT/Commissioning, and validation packages.

Biopuremax operates a direct enterprise sales model with no disclosed channel partners, supported by trade show presence (FCE Brazil, PDA Europe) and digital marketing via LinkedIn, YouTube, and webinars. Revenue is generated through three streams: one-time system sales, professional services for installation and commissioning, and after-sale services (filter and UV lamp replacement). The company is privately held with no disclosed funding rounds, parent company, or acquisition activity, and in July 2025 announced a strategic partnership with Insatech (Denmark) to broaden its equipment, instrumentation, and automation capabilities for the pharmaceutical and biotech end markets.

Name

Biopuremax

Legal name

Biopuremax

Website

https://biopuremax.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

11–50 employees

Short description

Biopuremax is a privately held Israeli company that designs, supplies, and commissions chemical-free, media-free pharmaceutical water purification systems (PW and WFI) for enterprise pharmaceutical and biotech customers, using proprietary ESR, HOD, CBR, and HWS technologies compliant with USP, EP, and ISO 22519.

Ownership category

akta.pro rank

Product category

Pharmaceutical Water Purification Systems

NAICS

Other Basic Inorganic Chemical Manufacturing (325180)

SIC

Miscellaneous Chemical Products (2890)

akta.pro primary industry

Water Treatment & Process Specialty Chemicals (IMAEABAN)

akta.pro secondary industries

Industrial Wastewater Treatment Chemicals (IMAEAJAC), Cooling Water Treatment Chemicals (IMAEAJAE)

Keywords

• Pharmaceutical water systems
• Water for injection
• Purified water treatment
• Biopharmaceutical equipment
• RO pretreatment systems

Headquarters

HQ city

Herzliya

HQ country

Israel

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

1. Water Purification Systems: Sale of complete pharmaceutical water treatment systems including pretreatment, PW production, WFI systems, storage and distribution. Systems are custom-designed per client capacity needs (ranging from 0.5 m3/hr to 9.5 m3/hr). Includes FAT (Factory Acceptance Test), fabrication, programming, and design approval process.
2. Installation and Commissioning Services: Full installation, commissioning, and SAT services for Biopuremax systems. Complete validation package available for regulatory compliance.
3. After-Sale Services: Replacement of filters and UV lamps as ongoing maintenance. Scale precipitated in ESR automatically removed by cleaning cycle. After sales support and service.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Biopuremax designs, manufactures, and installs standardized chemical-free, media-free pharmaceutical water purification systems for the pharma and biotech industries. The company offers complete Pretreatment, Purified Water (PW), and Water for Injection (WFI) systems based on its proprietary ESR™ (Electrolytic Scale Reduction) and HOD™ (Hydro Optical De-Chlorination) technologies combined with RO, CEDI, and UF processes, including installation, commissioning, validation, and after-sale services.

Product overview

Biopuremax is a pharmaceutical water purification company offering a standardized package system for chemical-free, media-free water treatment. The core product portfolio centers on ESR™ (Electrolytic Scale Reduction), HOD™ (Hydro Optical De-Chlorination), and CBR™ (Continuous Bioburden Reduction) technologies combined with Hot Water Sanitization (HWS). These pretreatment technologies feed into RO (Reverse Osmosis), CEDI (Continuous Electro De-Ionization), and UF (Ultra Filtration) systems to produce Purified Water (PW) and Water for Injection (WFI) compliant with USP, EP, and ISO 22519 standards. The company provides complete A-to-Z systems including design, fabrication, installation, commissioning, validation, and after-sales services for pharmaceutical and biotech industries worldwide.

Differentiator

Problem solved

Functional benefit

Brands

• ESR™ (Electrolytic Scale Reduction): Electrolytic technology for scale reduction in water treatment systems
• HOD™ (Hydro Optical De-Chlorination)
• CBR™ (Continuous Bioburden Reduction)
• HWS (Hot Water Sanitization)

Products and services

• Biopuremax Pretreatment System Standardized pharmaceutical water pretreatment package providing chemical-free and media-free RO feed water for pharmaceutical and biotech manufacturers. Combines ESR™ and HOD™ technologies in a compact skid design with small footprint and low floor loading, eliminating softeners, carbon filters, and regeneration chemicals.
• PW (Purified Water) System Pharmaceutical purified water production system meeting USP standards. Uses Biopuremax pretreatment combined with RO and CEDI to deliver consistent, low-bacteria purified water suitable for pharmaceutical manufacturing.
• WFI (Water for Injection) System Water for Injection production system using non-distillation membrane technologies (RO + CEDI + UF) compliant with European Pharmacopeia and US Pharmacopeia standards. Provides zero total bacteria count per ml with high reliability.
• Single Pass RO + CEDI + UF WFI System Standard WFI system design using single pass RO membrane, CDI, and Ultra Filtration for water for injection production. Includes multimedia filter, ESR™, HOD™ UV, hot water sanitizable RO, CO2 degasser, and hot water sanitizable CEDI.
• Double Pass RO + CEDI WFI System WFI system design using double pass RO membrane with CEDI for water for injection production. Features hot water sanitization, CO2 degasser, and dual-stage purification.
• Demonstration Unit Portable demonstration skid for placement in customer factories to showcase RO pretreatment with ESR™-HOD™ technology. Produces 100-250 L/hr with no need for softeners or chemicals, used as a sales tool and proof-of-concept.
• ESR™ (Electrolytic Scale Reduction) Technology Electrolytic scale reduction technology sold as part of integrated water treatment systems, precipitating scale-forming ions (calcium, magnesium, silica, iron, manganese) through high pH near the cathode, automatically removed by cleaning cycle. Generates free chlorine from naturally occurring chloride for bacterial reduction.
• HOD™ (Hydro Optical De-Chlorination) Technology UV-based dechlorination technology sold as part of integrated water treatment systems, decomposing free chlorine, chloramines, ozone, and chlorine dioxide from feed water while providing disinfection as a byproduct of the dechlorination process.
• CBR™ (Continuous Bioburden Reduction) Technology
• HWS (Hot Water Sanitization) Technology

Quantifiable outcome

• Up to 30% savings on feed water compared to traditional pharmaceutical water treatment systems
• +3 more outcomes

Named customers18 records

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• InsatechcoreTechnology or Integration · 14 July 2025Partnership with Insatech, a leading Danish equipment, instrumentation and automation company. Partnership aligns with vision to deliver technology driven PW/WFI systems, free from bacteria, chemicals, and media for pharmaceutical and biotech industries. Insatech provides equipment, instrumentation and automation expertise to complement Biopuremax's water purification technology.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Kurita Water Industries: Japanese-headquartered industrial water treatment and specialty chemicals company serving semiconductor, power, and pharmaceutical customers. Comparable in industrial water-purification technology, particularly membrane and ion-exchange based systems.
• SUEZ Water Technologies & Solutions: Global water services provider with a strong pharma/biotech water systems portfolio including PW, WFI, and process water solutions. Directly comparable in target customer (pharma manufacturers) and overlapping technology stack.
• Veolia Water Technologies (now Veolia): Global water-treatment major with a dedicated pharma/life-sciences portfolio producing PW, WFI, pure steam and distribution systems. Comparable to Biopuremax in target end-market, but broader scope and significantly larger scale.
• Ecolab Life Sciences (including previous Purolite and Nalco Water assets): Global specialty chemicals/services leader with pharmaceutical water treatment and purification solutions serving drug manufacturers. Competes with Biopuremax on enterprise pharma water accounts from a much broader portfolio.

Direct peers

• Organo Corporation: Japanese water and process-treatment specialist with dedicated pharmaceutical water systems (PW, WFI, pure steam) using membrane and ion-exchange technologies. Comparable niche player focused on pharma/biotech water.
• BWT (Best Water Technology): European-headquartered water-treatment group with pharmaceutical-grade water (PW/WFI) systems and service offerings. Comparable to Biopuremax in pharma water treatment focus and European go-to-market.
• Christ Water Technology / Aqua Solutions: Pharmaceutical and high-purity water systems integrator (formerly Christ Water Technology) producing PW and WFI systems for drug manufacturers. Direct comparable as a specialist pharma water systems integrator.
• Mar Cor Purification (Cantel Medical / Ecolab subsidiary): Specialist in water treatment for pharmaceutical, medical, and laboratory applications, with PW, WFI and dialysis water systems. Directly comparable niche specialist competing for the same enterprise pharma clients.
• Pentair (X-Flow membrane business): Industrial water treatment and membrane filtration specialist offering RO, UF and NF systems for pharmaceutical-grade water. Comparable to Biopuremax in core membrane technology for PW/WFI production, with broader industrial reach.

Regional players

• Syntegon (formerly Bosch Packaging Technology): Processing and packaging equipment supplier to the pharma industry that also offers water treatment system solutions for pharmaceutical customers. Adjacent overlap with Biopuremax in pharma facility buildouts and project lifecycle.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/watch?v=5FuDq4R7-Uc
• LinkedInlinkedin.com/company/biopuremax

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biopuremax